Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019)

Updated

Chemomab Therapeutics' Change in Receivables was -$3.78 million in Q4 2019, compared with $5.91 million a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Change in Receivables (2018 - 2019) Analysis & Trends

For FY2019, Change in Receivables at Chemomab Therapeutics came in at -$2.31 million.

  • In earlier years, Change in Receivables was $3.5 million in FY2018, $204,000 in FY2017 (+75.9%) and $116,000 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -3.78 Mn
Sep 30, 2019 -351,000.00
Dec 31, 2018 5.91 Mn
Sep 30, 2018 -2.50 Mn
API Access

Chemomab Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CMMB&period=max&api_key=YOUR_API_KEY